ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

RARE Ultragenyx Pharmaceutical Inc

42.75
-0.45 (-1.04%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Ultragenyx Pharmaceutical Inc RARE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.45 -1.04% 42.75 09:00:00
개장가 저가 고가 종가 전일 종가
44.88 42.675 46.005 42.75 43.20
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:00GLOBEUltragenyx Reports First Quarter 2024 Financial Results and..
01/05/202405:00GLOBEUltragenyx Issues 2023 Corporate Responsibility Report,..
30/04/202421:00GLOBEUltragenyx Announces Completion of Enrollment in Phase 3..
26/04/202405:30GLOBEUltragenyx to Host Conference Call for First Quarter 2024..
20/04/202405:30GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
15/04/202420:00GLOBEUltragenyx Announces Positive Interim Phase 1/2 Data in..
13/04/202405:22GLOBEUltragenyx Announces Update to Conference Call Timing to..
12/04/202421:00GLOBEUltragenyx Announces Upcoming Data Presentations at American..
23/03/202405:00GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
06/03/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:30GLOBEUltragenyx to Participate at Investor Conferences in March
24/02/202406:05GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
22/02/202407:03EDGAR2Form S-3ASR - Automatic shelf registration statement of..
16/02/202406:04EDGAR2Form 8-K - Current report
16/02/202406:01GLOBEUltragenyx Reports Fourth Quarter and Full Year 2023..
09/02/202406:00GLOBEUltragenyx to Host Conference Call for Fourth Quarter and..
06/02/202422:00GLOBEUltragenyx Announces Data Demonstrating Treatment with UX111..
06/02/202406:05GLOBEUltragenyx Receives PRIME Designation from European..
26/01/202406:05GLOBEUltragenyx Announces Completion of Dosing Across Stage 1..
20/01/202406:00GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
08/01/202421:00GLOBEMereo BioPharma Provides Update on Pipeline Progress and..
08/01/202420:03EDGAR2Form 8-K - Current report
08/01/202401:00GLOBEUltragenyx Reports Preliminary 2023 Revenue; Guidance for..
04/01/202422:00GLOBEUltragenyx Receives Positive Recommendation from NICE in the..
03/01/202422:00GLOBEUltragenyx Announces Completion of Enrollment in Global..
03/01/202406:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202406:05GLOBEUltragenyx to Present at the 42nd Annual J.P. Morgan..
22/12/202307:45DJNUltragenyx to Pay $6 Million to Settle Alleged False..
22/12/202306:30GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
22/12/202306:02EDGAR2Form 8-K - Current report
18/12/202322:00GLOBEUltragenyx Receives European Commission Decision for..
21/11/202306:30GLOBEUltragenyx to Participate at Investor Conferences in..
18/11/202306:30GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
08/11/202307:00GLOBEUltragenyx to Participate in the Jefferies London Healthcare..
03/11/202305:17EDGAR2Form 8-K - Current report
03/11/202305:05GLOBEUltragenyx Reports Third Quarter 2023 Financial Results and..
27/10/202305:05GLOBEUltragenyx to Host Conference Call for Third Quarter 2023..
24/10/202305:01GLOBEUltragenyx Announces Closing of Public Offering of Common..
23/10/202319:31EDGAR2Form 8-K - Current report
21/10/202305:00GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
20/10/202319:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/10/202310:16GLOBEUltragenyx Announces Pricing of Public Offering of Common..
18/10/202305:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/10/202305:02GLOBEUltragenyx Announces Proposed Public Offering of Common..

최근 히스토리

Delayed Upgrade Clock